Toxic Epidermal Necrolysis (Lyell syndrome): a pathology for burn units. | Canada Hyperbarics Skip to main content
Clinical Study Acta medica portuguesa 2004

Toxic Epidermal Necrolysis (Lyell syndrome): a pathology for burn units.

Cabral L, Diogo C, Riobom F, Teles L, Cruzeiro C — Acta medica portuguesa, 2004

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented the treatment protocol for Toxic Epidermal Necrolysis (TEN) used at the Coimbra Burns Unit in Portugal, illustrated with a clinical case.

What They Found

Toxic Epidermal Necrolysis (TEN) is a rare but serious dermatological condition characterized by high fever, systemic toxicity, and intense mucocutaneous exfoliation, often leading to high morbidity and mortality, primarily due to sepsis. Effective management requires immediate drug suspension and early admission to specialized burn units for intensive support, infection control, surgical debridement, and covering of affected areas. Several therapeutic measures, such as plasmapheresis, N-acetylcysteine, immunosuppression, and hyperbaric oxygen, are currently under investigation to reduce morbidity and mortality.

Canadian Relevance

This study has no direct Canadian connection as it describes a treatment protocol from a burn unit in Portugal. However, the principles of managing Toxic Epidermal Necrolysis in specialized burn units are universally applicable.

Study Limitations

This study is limited by its descriptive nature, presenting a single institution's protocol and a single clinical case, thus lacking broader generalizability or comparative outcome data.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 15921643
Year Published 2004
Journal Acta medica portuguesa
MeSH Terms Burn Units; Clinical Protocols; Diagnosis, Differential; Humans; Stevens-Johnson Syndrome

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology